What smart money is saying about Azenta, Inc.
AZTA
No fund has written a full thesis on Azenta, Inc. in our archive, but 1 fund letter reports a position in it, most recently Conestoga Capital Advisors Small Cap, SMid Cap & Micro Cap Growth Composites in June 2026.
Get an email when a fund buys, sells or pitches it
1
Reported positions
0
Bought
1
Sold
1
Letter
Position history
Every position in Azenta, Inc. on record in the archive was reported in Q2 2026, across 1 fund letter, with 1 sell (trimmed or exited).
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q2 2026 | 1 | 0 | 1 | 0 |
Bought and Sold count moves: the same sentence published by several funds of one house in a quarter counts once.
Fund activity · 1 position · 1 move
“4. Azenta, Inc. (AZTA) AZTA provides sample management, cold-chain, and multiomics solutions for the life sciences industry. We sold the position after execution challenges, weaker life sciences funding, and continued softness in capital equipment demand led management to lower its full- year outlook.”
Azenta, Inc.
Read the letters behind these Azenta, Inc. positions
Every quote above comes from a fund letter in our archive. Get unlimited access to the letters themselves, and to Warren AI, which reads all of them for you.
View plans→Share this ledger